Valutazione del libro
Maggiori informazioni sul libro
The long-awaited story of the science, business, politics, and intrigue behind the fierce competition to map the human genome unfolds dramatically. On May 10, 1998, biologist Craig Venter announced the formation of a private company aimed at unraveling the complete genetic code of human life within three years—seven years ahead of the U.S. government's Human Genome Project. Venter's ambition was not only to accelerate biomedical research and save lives but also to achieve fame and fortune. He named his company Celera, meaning "speed," and gathered a small team of scientists in Rockville, Maryland, to embark on this groundbreaking mission. Simultaneously, the government program, led by Francis Collins of the National Human Genome Research Institute, rallied a unified effort to outpace Venter. This rivalry set the stage for a thrilling and significant drama in scientific history. The narrative captures the race for the most coveted prize in biology, with exclusive insights into Venter’s operation. It also explores how one man's ambition sparked a scientific Camelot, where the interests of pure science and commercial profit appeared to align—only to reveal the national repercussions when that vision faltered.
Acquisto del libro
The Genome War, James Shreeve
- Lingua
- Pubblicato
- 2005
- product-detail.submit-box.info.binding
- (In brossura)
Metodi di pagamento
Qui potrebbe esserci la tua recensione.
- Titolo
- The Genome War
- Sottotitolo
- How Craig Venter Tried to Capture the Code of Life and Save the World
- Lingua
- Inglese
- Autori
- James Shreeve
- Pubblicato
- 2005
- Formato
- In brossura
- Pagine
- 416
- ISBN10
- 0345433742
- ISBN13
- 9780345433749
- Serie
- Tag
- Saggistica, Tema stórico, Storie vere, Biografie, Scienza e Matematica, Scienze Naturali, Biologia, Scienza, Biografie, Storie di vita, Memorie, Ispirazione, Genetica, Storia della Scienza, Libri motivazionali
- Valutazione
- 3,85 su 5
- Descrizione
- The long-awaited story of the science, business, politics, and intrigue behind the fierce competition to map the human genome unfolds dramatically. On May 10, 1998, biologist Craig Venter announced the formation of a private company aimed at unraveling the complete genetic code of human life within three years—seven years ahead of the U.S. government's Human Genome Project. Venter's ambition was not only to accelerate biomedical research and save lives but also to achieve fame and fortune. He named his company Celera, meaning "speed," and gathered a small team of scientists in Rockville, Maryland, to embark on this groundbreaking mission. Simultaneously, the government program, led by Francis Collins of the National Human Genome Research Institute, rallied a unified effort to outpace Venter. This rivalry set the stage for a thrilling and significant drama in scientific history. The narrative captures the race for the most coveted prize in biology, with exclusive insights into Venter’s operation. It also explores how one man's ambition sparked a scientific Camelot, where the interests of pure science and commercial profit appeared to align—only to reveal the national repercussions when that vision faltered.